Skip to main content
. 2019 May 8;14(5):e0216386. doi: 10.1371/journal.pone.0216386

Table 1. Sample characteristics.

Characteristics Mean (SD) / N (%)
Follow-up (months) 5.6 (1.1)
Women (%) 174 (85.7%)
Age (years) 55 (14.2)
BMI (kg/m2) 27 (6.6)
Lymphedema type:
 • Primary 69 (34%)
 • Secondary 134 (66%)
Lymphedema location:
 • Upper Limb 95 (46.8%)
 • Lower Limb 105 (51.7%)
 • Upper and lower limbs 3 (1.5%)
Lymphedema severity:
 • Stage 1 21 (10.4%)
 • Stage 2 163 (80.3%)
 • Stage 3 19 (9.3%)
Lymphedema duration:
 • from 6 months to 5 years 105 (51.7%)
 • from 5 years to 10 years 28 (13.8%)
 • above 10 years 70 (34.5%)
Comorbidities:
 • None 132 (65%)
 • Cancer 44 (21.7%)
 • Others 27 (13.3%)
Wound infection 40 (19.7%)
Hospitalization because of wound infection 30 (14.8%)
Household size (CU) 1.7 (0.7)
Household monthly income (€) 3,320 (1,861)
Monthly income per CU (€) 2,012 (1,191)
Socio-professional category:
 • Active 123 (60.6%)
 • Inactive 18 (8.9%)
 • Retired 62 (30.5%)
Voluntary Health Insurance (VHI) (%) 198 (97.5%)
VHI upgrade for lymphedema care 47 (23.2%)
VHI annual premium (€) 1,293 (788)
Chronic illness exemption scheme (ALD) 144 (70.9%)
Social complementary health insurance (CMUc or ACS) 4 (2%)

SD: standard deviation; BMI: body mass index; CU: consumption unit; VHI: voluntary health insurance; ALD: affection de longue duree; CMUc: couverture maladie universelle complementaire; ACS: aide a la complementaire sante.